Emergent Biosolutions Inc (EBS)
Fair Value7.2% Upside
Fair
Analyst62.7% Upside
Market Cap346.6 M
P/E—
Yield0.0%
HealthGreat
NYSE
Lineage Cell Therapeutics Inc (LCTX)
Fair Value12.1% Upside
Fair
Analyst428.8% Upside
Market Cap263 M
P/E—
Yield0.0%
HealthFair
NYSE
AbbVie Inc (ABBV)
Fair Value-10.5% Downside
Fair
Analyst5.1% Upside
Market Cap468.7 B
P/E74.7x
Yield2.6%
HealthGreat
NYSE
Actinium Pharmaceuticals Inc (ATNM)
Fair Value30.9% Upside
Undervalued
Analyst207.7% Upside
Market Cap36.786 M
P/E3.3x
Yield0.0%
HealthGreat
NYSE
Armata Pharmaceuticals Inc (ARMP)
Fair Value-24.4% Downside
Overvalued
Analyst316.7% Upside
Market Cap156.2 M
P/E—
Yield0.0%
HealthWeak
NYSE
CEL-SCI Corp (CVM)
Fair Value46.5% Upside
Undervalued
Analyst635.3% Upside
Market Cap29.901 M
P/E—
Yield0.0%
HealthFair
NYSE
Perspective Therapeutics Inc (CATX)
Fair Value-7.9% Downside
Fair
Analyst315.1% Upside
Market Cap337.9 M
P/E—
Yield0.0%
HealthWeak
NYSE
Protalix Biotherapeutics Inc (PLX)
Fair Value-18.9% Downside
Overvalued
Analyst287.3% Upside
Market Cap228.8 M
P/E12.1x
Yield0.0%
HealthGreat
NYSE
Theriva Biologics Inc (TOVX)
Fair Value15.1% Upside
Fair
Analyst983.2% Upside
Market Cap10.592 M
P/E—
Yield0.0%
HealthWeak
NYSE
Arcus Biosciences Inc (RCUS)
Fair Value-8.7% Downside
Fair
Analyst44.2% Upside
Market Cap3.421 B
P/E—
Yield0.0%
HealthWeak
NYSE
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
Fair Value7.7% Upside
Fair
Analyst43.2% Upside
Market Cap2.243 B
P/E—
Yield0.0%
HealthWeak
NYSE
Can Fite Biopharma Ltd ADR (CANF)
Fair Value55.4% Upside
Bargain
Analyst258.7% Upside
Market Cap4.834 M
P/E—
Yield0.0%
HealthWeak
NYSE
Matinas BioPharma Holdings Inc (MTNB)
Fair Value31.0% Upside
Undervalued
Market Cap2.601 M
P/E—
Yield0.0%
HealthFair
NYSE
NanoViricides Inc (NNVC)
Fair Value-40.6% Downside
Overvalued
Analyst292.2% Upside
Market Cap34.854 M
P/E—
Yield0.0%
HealthFair
NYSE
Oragenics Inc (OGEN)
Fair Value30.0% Upside
Undervalued
Market Cap2.346 M
P/E—
Yield0.0%
HealthFair
NYSE
Adc Therapeutics SA (ADCT)
Fair Value9.0% Upside
Fair
Analyst171.0% Upside
Market Cap157 M
P/E—
Yield0.0%
HealthFair
NYSE
Aeon Biopharma Inc (AEON)
Fair Value-2.3% Downside
Fair
Analyst486.5% Upside
Market Cap13.069 M
P/E—
Yield0.0%
HealthFair
NYSE
Annovis Bio Inc (ANVS)
Fair Value5.2% Upside
Fair
Analyst733.3% Upside
Market Cap53.684 M
P/E—
Yield0.0%
HealthWeak
NYSE
Serina Therapeutics Inc (SER)
Fair Value11.2% Upside
Fair
Analyst311.3% Upside
Market Cap58.675 M
P/E—
Yield0.0%
HealthWeak
NYSE
AIM ImmunoTech Inc (AIM)
Fair Value23.1% Upside
Undervalued
Market Cap6.563 M
P/E—
Yield0.0%
HealthWeak
NYSE
Azitra Inc (AZTR)
Fair Value27.0% Upside
Undervalued
Analyst354.3% Upside
Market Cap10.339 M
P/E—
Yield0.0%
HealthWeak
NYSE
Calidi Biotherapeutics Inc (CLDI)
Fair Value39.4% Upside
Undervalued
Market Cap4.102 M
P/E—
Yield0.0%
HealthWeak
NYSE
Evommune Inc (EVMN)
Fair Value9.7% Upside
Fair
Analyst151.3% Upside
Market Cap348.4 M
P/E—
Yield0.0%
HealthFair
NYSE
Kairos Pharma Ltd (KAPA)
Fair Value31.5% Upside
Undervalued
Market Cap6.026 M
P/E—
Yield0.0%
HealthWeak
NYSE
Maia Biotechnology Inc (MAIA)
Fair Value-1.2% Downside
Fair
Analyst775.9% Upside
Market Cap83.331 M
P/E—
Yield0.0%
HealthWeak
NYSE
OS Therapies Inc (OSTX)
Fair Value3.1% Upside
Fair
Analyst380.2% Upside
Market Cap81.643 M
P/E—
Yield0.0%
HealthWeak
NYSE
Pelthos Therapeutics Inc (PTHS)
Fair Value25.4% Upside
Undervalued
Analyst128.7% Upside
Market Cap88.974 M
P/E—
Yield0.0%
HealthFair
NYSE
Regentis Biomaterials Ltd (RGNT)
Fair Value-37.1% Downside
Overvalued
Analyst378.5% Upside
Market Cap14.68 M
P/E—
Yield0.0%
HealthFair
NYSE